These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 865569)

  • 1. L-dopa effects on renal function.
    Goldberg LI
    N Engl J Med; 1977 Jul; 297(2):112-3. PubMed ID: 865569
    [No Abstract]   [Full Text] [Related]  

  • 2. L-dopa effects on renal function in obese subjects.
    Banasiak MF; Marshall WP; Kalkhoff RK
    N Engl J Med; 1977 May; 296(19):1122. PubMed ID: 850528
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of the dopaminergic structures of the kidney in the renal effects of euphyllin].
    Kantariia VA
    Farmakol Toksikol; 1977; 40(3):331-3. PubMed ID: 902724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal effects of L-DOPA in heart failure.
    Grossman E; Shenkar A; Peleg E; Thaler M; Goldstein DS
    J Cardiovasc Pharmacol; 1999 Jun; 33(6):922-8. PubMed ID: 10367596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement by L-dopa of the renal action of aldosterone in the rat.
    Adam WR
    Clin Exp Pharmacol Physiol; 1979; 6(1):87-96. PubMed ID: 761430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects in L-dopa treated parkinsonian patients [proceedings].
    Granerus AK; Jagenburg R; Svanborg A
    Aktuelle Gerontol; 1978 Oct; 8(10):544. PubMed ID: 30303
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal dopamine excretion in healthy volunteers after oral ingestion of L-dopa.
    Barthelmebs M; Mbou P; Stephan D; Grima M; Imbs JL
    Fundam Clin Pharmacol; 1993; 7(1):11-6. PubMed ID: 8458598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of intravenous L-dopa on plasma renin activity, renal function, and blood pressure in man.
    Worth D; Harvey J; Brown J; Lee M
    Eur J Clin Pharmacol; 1988; 35(2):137-41. PubMed ID: 3056728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal dopamine synthesis from precursors.
    Barthelmebs M; Vailly B; Velly J; Ehrhardt JD; Grima M; Imbs JL
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):18S-21S. PubMed ID: 2116809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of renal dopamine synthesis in the diuretic effect of furosemide in normohydrated rats.
    Nowicki S; Levin G; Enero MA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1377-80. PubMed ID: 8450472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine activates aromatic L-amino acid decarboxylase activity in the kidney and increases dopamine.
    Takezako T; Noda K; Tsuji E; Koga M; Sasaguri M; Arakawa K
    J Am Soc Nephrol; 2001 Jan; 12(1):29-36. PubMed ID: 11134247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the pharmacology of the inward transport of L-DOPA in rat renal tubules.
    Pinto-do-O PC; Soares-da-Silva P
    Br J Pharmacol; 1996 Jun; 118(3):741-7. PubMed ID: 8762102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal hemodynamic response to l-dopa during acute renal failure in man.
    Zech P; Collard M; Guey A; Plantier J; Beruard M; Berthoux F; Pinet A; Traeger J
    Biomedicine; 1975 Dec; 23(10):456-60. PubMed ID: 1222222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrarenal dopamine participation in frusemide diuretic and natriuretic responses to frusemide.
    Nowicki S; Ochoa EJ; Levin G; Elias MM
    J Auton Pharmacol; 1995 Jun; 15(3):159-68. PubMed ID: 7673270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional haemodynamic effects of dopamine and its prodrugs L-dopa and gludopa in the rat and in the glycerol-treated rat as a model for acute renal failure.
    Drieman JC; van Kan FJ; Thijssen HH; van Essen H; Smits JF; Struijker Boudier HA
    Br J Pharmacol; 1994 Apr; 111(4):1117-22. PubMed ID: 8032598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gamma-Glutamyl dopa: a kidney-specific dopamine precursor.
    Wilk S; Mizoguchi H; Orlowski M
    J Pharmacol Exp Ther; 1978 Jul; 206(1):227-32. PubMed ID: 660553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable.
    Shigetomi S; Kuchel O
    Am J Hypertens; 1993 Jan; 6(1):33-40. PubMed ID: 8427659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaliuretic effect of L-dopa treatment in parkinsonian patients.
    Granérus AK; Jagenburg R; Svanborg A
    Acta Med Scand; 1977; 201(4):291-97. PubMed ID: 851038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal response to infusion of dopamine precursors in anaesthetized rats.
    Mühlbauer B; Gleiter CH; Gies C; Luippold G; Löschmann PA
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):838-45. PubMed ID: 9453471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
    Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.